Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,550 | 16,435 | 20,355 | 0 | 0 |
| Receivables | 136 | 12 | 8 | 0 | 0 |
| TOTAL | $12,983 | $16,727 | $20,660 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,119 | 356 | 145 | N/A | N/A |
| Intangibles | 4,714 | 4,329 | 7,962 | 0 | 0 |
| Other Non-Current Assets | 12,446 | 12,939 | 12,446 | 0 | 0 |
| TOTAL | $18,279 | $17,624 | $20,553 | $N/A | $N/A |
| Total Assets | $31,262 | $34,351 | $41,213 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,366 | 879 | 2,147 | 0 | 0 |
| TOTAL | $1,366 | $879 | $2,391 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 244 | N/A | N/A |
| Other Non-Current Liabilities | 38,917 | 57,579 | 57,662 | 0 | 0 |
| TOTAL | $38,917 | $57,579 | $60,740 | $N/A | $N/A |
| Total Liabilities | $40,283 | $58,458 | $63,131 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27 | 26 | N/A | N/A | N/A |
| Common Shares | 1,872 | 1,825 | 1,825 | 0 | 0 |
| Retained earnings | -374,700 | -394,833 | -385,115 | 0 | 0 |
| Other shareholders' equity | -85 | -69 | 707 | 0 | 0 |
| TOTAL | $-9,021 | $-24,107 | $-21,918 | $0 | $0 |
| Total Liabilities And Equity | $31,262 | $34,351 | $41,213 | $0 | $0 |